Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Ioanna Skorta"'
Autor:
Heiko van der Kuip, Walter E. Aulitzky, Matthias Gutekunst, Christiane Markwardt, Moshe Oren, Ioanna Skorta
Imatinib is highly effective in inducing remission in chronic myelogenous leukemia (CML). However, complete eradication of the malignant clone by imatinib is rare. We investigated the efficacy of combining imatinib with cisplatin. Inhibition of Bcr-A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::40fa57d1328c79507027970ef4de6393
https://doi.org/10.1158/0008-5472.c.6499484.v1
https://doi.org/10.1158/0008-5472.c.6499484.v1
Autor:
Heiko van der Kuip, Walter E. Aulitzky, Matthias Gutekunst, Christiane Markwardt, Moshe Oren, Ioanna Skorta
Supplementary Figure 3 from Imatinib Mesylate Induces Cisplatin Hypersensitivity in Bcr-Abl+ Cells by Differential Modulation of p53 Transcriptional and Proapoptotic Activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1dd2674f8a5f2e3e4444091ade231a8f
https://doi.org/10.1158/0008-5472.22380179
https://doi.org/10.1158/0008-5472.22380179
Autor:
Heiko van der Kuip, Walter E. Aulitzky, Matthias Gutekunst, Christiane Markwardt, Moshe Oren, Ioanna Skorta
Supplementary Figure 1 from Imatinib Mesylate Induces Cisplatin Hypersensitivity in Bcr-Abl+ Cells by Differential Modulation of p53 Transcriptional and Proapoptotic Activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8bc5c7ef3500348da4e4a452b0f7d36
https://doi.org/10.1158/0008-5472.22380185.v1
https://doi.org/10.1158/0008-5472.22380185.v1
Autor:
Heiko van der Kuip, Walter E. Aulitzky, Matthias Gutekunst, Christiane Markwardt, Moshe Oren, Ioanna Skorta
Supplementary Figures 1-3 from Imatinib Mesylate Induces Cisplatin Hypersensitivity in Bcr-Abl+ Cells by Differential Modulation of p53 Transcriptional and Proapoptotic Activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d11b88f6e66462065081e6dd38140c4
https://doi.org/10.1158/0008-5472.22380176
https://doi.org/10.1158/0008-5472.22380176
Autor:
Heiko van der Kuip, Walter E. Aulitzky, Matthias Gutekunst, Christiane Markwardt, Moshe Oren, Ioanna Skorta
Supplementary Figure 2 from Imatinib Mesylate Induces Cisplatin Hypersensitivity in Bcr-Abl+ Cells by Differential Modulation of p53 Transcriptional and Proapoptotic Activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1116d93f065f94e79b01392a2877a46e
https://doi.org/10.1158/0008-5472.22380182.v1
https://doi.org/10.1158/0008-5472.22380182.v1
Autor:
H van der Kuip, Walter E. Aulitzky, Ioanna Skorta, Maike Sonnenberg, Cornelius Miething, Silke Fanta, Justus Duyster
Publikováno v:
Oncogene. 27:4380-4384
Imatinib inhibits the kinase activity of Bcr-Abl and is currently the most effective drug for treatment of chronic myeloid leukemia (CML). Imatinib also blocks c-Abl, a physiological tyrosine kinase activated by a variety of stress signals including
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9804ff4c6d738f127ccd6e371781134b
https://doi.org/10.1038/onc.2008.68
https://doi.org/10.1038/onc.2008.68
Autor:
Walter E. Aulitzky, Christiane Markwardt, Matthias Gutekunst, Heiko van der Kuip, Moshe Oren, Ioanna Skorta
Publikováno v:
Cancer research. 69(24)
Imatinib is highly effective in inducing remission in chronic myelogenous leukemia (CML). However, complete eradication of the malignant clone by imatinib is rare. We investigated the efficacy of combining imatinib with cisplatin. Inhibition of Bcr-A
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6fec2ed3dae3eba6a2d1f0e29cd507a4
https://pubmed.ncbi.nlm.nih.gov/19934315
https://pubmed.ncbi.nlm.nih.gov/19934315
Publikováno v:
Blood. 110:2954-2954
Imatinib is highly effective in inducing remissions in chronic phase CML. However, complete eradication of the malignant clone by Imatinib monotherapy is rare. This prompted us to explore the efficacy of combination of Imatinib with the DNA damaging
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::72092870e2d0e04ed1322c106b7507d0
https://doi.org/10.1182/blood.v110.11.2954.2954
https://doi.org/10.1182/blood.v110.11.2954.2954